Atlas Trials

Neoadjuvant Radiotherapy Combined With Toripalimab for Locally Advanced Head and Neck Squamous Cell Carcinoma

Clinical trial NCT05861557 · UNKNOWN

Trial details

NCT number
NCT05861557
Sponsor
Tianjin Medical University General Hospital
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Locally Advanced Head and Neck Squamous Cell Carcinoma
Start date
2023-05-20
Primary completion
2024-05-20
Enrollment
23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.